Cannabis Stock News Daily Roundup July 12

GGB) (OTCQB: GGBXF) has received a purchase order from American Eagle Outfitters (NYSE: AEO) for hemp-derived CBD infused personal care products. The deal will see GGB’s products hitting shelves at nearly 500 of American Eagle stores.” data-reactid=”11″>Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) has received a purchase order from American Eagle Outfitters (NYSE: AEO) for hemp-derived CBD infused personal care products. The deal will see GGB’s products hitting shelves at nearly 500 of American Eagle stores.

FIRE) (OTCQX: SPRWF) and Blissco Cannabis (CSE: BLIS) (OTCQB: HSTRF) reported receiving a final order from the Supreme Court of British Columbia that approves the plan of arrangement between Supreme and Blissco. Subject to the terms of an arrangement agreement, Supreme Cannabis will acquire all of the issued and outstanding common shares of Blissco not already owned by Supreme.” data-reactid=”12″>The Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) and Blissco Cannabis (CSE: BLIS) (OTCQB: HSTRF) reported receiving a final order from the Supreme Court of British Columbia that approves the plan of arrangement between Supreme and Blissco. Subject to the terms of an arrangement agreement, Supreme Cannabis will acquire all of the issued and outstanding common shares of Blissco not already owned by Supreme.

IAN) (OTCQX: ITHUF), is expanding its retail presence with a partnership with Dillard’s. The company’s CBD-infused wellness, self-care, and beauty products will be available throughout Dillard’s 265 department stores spanning 29 states.” data-reactid=”13″>CBD For Life, a subsidiary of iAnthus Capital Holdings (CSE: IAN) (OTCQX: ITHUF), is expanding its retail presence with a partnership with Dillard’s. The company’s CBD-infused wellness, self-care, and beauty products will be available throughout Dillard’s 265 department stores spanning 29 states.

ABCS) has received new retail purchase orders from CVS (NYSE: CVS) for its line of CBDMEDIC products. The company will supply two of its new CBDMEDIC dermatology products for Eczema and Itch & Rash in over 400 stores. Furthermore, these two products plus an additional eight CBDMEDIC pain products will move in-line in over 600 stores.” data-reactid=”14″>Abacus Health Products (CSE: ABCS) has received new retail purchase orders from CVS (NYSE: CVS) for its line of CBDMEDIC products. The company will supply two of its new CBDMEDIC dermatology products for Eczema and Itch & Rash in over 400 stores. Furthermore, these two products plus an additional eight CBDMEDIC pain products will move in-line in over 600 stores.

N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) has signed an agreement with 2103486 Alberta Ltd. operating as ARBR to incorporate NamasteMD into the ARBR clinical referral platform. ARBR is a web-based tool developed to help pharmacists and clinicians guide patients through their cannabis journey and support patients with questions or concerns, allowing them to select the right strain for their individual needs.” data-reactid=”15″>Namaste Technologies (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) has signed an agreement with 2103486 Alberta Ltd. operating as ARBR to incorporate NamasteMD into the ARBR clinical referral platform. ARBR is a web-based tool developed to help pharmacists and clinicians guide patients through their cannabis journey and support patients with questions or concerns, allowing them to select the right strain for their individual needs.

CGOC) has completed a new investment in PlantEXT Ltd., which is engaged in the development and commercialization of pharmaceutical cannabis formulations backed by pre-clinical and clinical studies for the treatment of inflammation-related medical conditions. CGOC made an investment of USD$500,000 for 400,000 shares in PlantEXT.” data-reactid=”16″>Cannabis Growth Opportunity (CSE: CGOC) has completed a new investment in PlantEXT Ltd., which is engaged in the development and commercialization of pharmaceutical cannabis formulations backed by pre-clinical and clinical studies for the treatment of inflammation-related medical conditions. CGOC made an investment of USD$500,000 for 400,000 shares in PlantEXT.

RMMI) announced that its Rocky Mountain Marijuana subsidiary submitted its Site Evidence Package to Health Canada as part of its cultivation, processing and sales license application under the cannabis act. The submission represents the final step in Rocky Mountain’s application process to obtain a license to cultivate cannabis at its Newell facility.” data-reactid=”17″>RMMI Corp. (CSE: RMMI) announced that its Rocky Mountain Marijuana subsidiary submitted its Site Evidence Package to Health Canada as part of its cultivation, processing and sales license application under the cannabis act. The submission represents the final step in Rocky Mountain’s application process to obtain a license to cultivate cannabis at its Newell facility.

Cannabis Stock News Daily Roundup July 12 appeared first on Market Exclusive.” data-reactid=”19″>The post Cannabis Stock News Daily Roundup July 12 appeared first on Market Exclusive.

Author: CSN